Cardiac Resynchronization Therapy Market – Advanced Devices Support Heart Failure Management
The cardiac resynchronization therapy, or CRT, market is growing as the prevalence of heart failure rises and healthcare providers adopt advanced implantable devices to help improve cardiac coordination in selected patients. The market was valued at USD 4.22 billion in 2024 and is projected to reach USD 7.7 billion by 2032, growing at a CAGR of 7.8%. 1180 Heart failure occurs when the heart...
0 Comments 0 Shares 119 Views 0 Reviews